It’s Time to Examine the Impact of Genetic Susceptibility on the Incidence of Diabetes among HIV-Infected Individuals
DOI:
https://doi.org/10.17140/HARTOJ-3-e008Abstract
The remarkable advances in application of anti-retroviral therapy (ART) to treat HIV infection has had a profound impact on the HIV epidemic as well as improved the quality and longevity of life for those who receive such treatment. Nonetheless, as individuals receiving ART live longer, they may develop chronic non-communicable disease at an increased incidence and/or severity when compared to non infected and/or untreated individuals. Prime examples of this include cardiovascular and neurological disease, as well as metabolic syndrome and diabetes mellitus.
References
Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalenceand incidence of diabetes mellitus in the Multicenter AIDS Cohort Study. Arch Intern Med. 2005; 165(10): 1179-1184. doi: 10.1001/archinte.165.10.1179
Capeau J, Bouteloup V, Katlama C, et al. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment. AIDS. 2012; 26: 303-314. doi: 10.1097/QAD.0b013e32834e8776
Jin C, Ji S, Xie t, et al. Severe dyslipidemia and immune activation in HIV patients with dysglycemia. HIV Clin Trials. 2016; 13: 1-8. doi: 10.1080/15284336.2016.1207297
Sobieszczyk ME, Werner L, Mlisana K, et al. Metabolic syndrome after HIV acquisition in South African women. J Acquir Im-mune Defic Syndr. 2016. doi: 10.1097/QAI.0000000000001123
Dimala CA, Atashili J, Mbuagbaw JC, Wilfred A, Monekosso GL. A comparison of the diabetes risk score in HIV/AIDS patients on highly active antiretroviral therapy (HAART) and HAART-naïve patients at the Limbe regional hospital, Cameroon. PLoS One. 2016; 11(5): e0155560. doi: 10.1371/journal.pone.0155560
Moreira RC, Pacheco AG, Paula A, et al. Diabetes mellitus is associated with increased death rates among HIV-infected patients in Rio de Janeiro, Brazil. AIDS Res Hum Retroviruses. 2016. doi: 10.1089/aid.2015.0265
Brar I, Shuter J, Thomas A, et al. A comparison of factors associated with prevalent diabetes mellitus among HIV-infected antiret-roviral-naive individuals versus individuals in the national health and nutritional examination survey cohort. J Acquir Immune Defic Syndr. 2007; 45(1): 66-71. doi: 10.1097/QAI.0b013e318031d7e3
Noor MA, Lo JC, Mulligan K, et al. Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS. 2001; 15(7): F11- F18. Web site. http://journals.lww.com/aidsonline/pages/articleviewer.aspx?year=2001&issue=05040&article=00001&type=abstra ct. Accessed August 5, 2016
Fuchsburger C, Flannick J, Teslovich TM, et al. The genetic architecture of type 2 diabetes. Nature. 2016; 536(7614): 41-47. doi:
1038/nature18642 10. Gaulton KJ, Ferreira T, Lee Y, et al. Genetic fine-mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet. 2015; 47: 1415-1425. doi: 10.1038/ng.3437
Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010; 42: 579-589. doi: 10.1038/ng.609
Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015; 518(7538): 197-206. doi: 10.1038/nature14177 HIV/AIDS Res Treat Open J Page e2
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in HIV/AIDS Research and Treatment (HRT) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
